# ClinicalTrials.gov record history: NCT01263717

- Peptide profile: [tesamorelin](https://peptidescanner.com/peptides/tesamorelin/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct01263717-tesamorelin/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct01263717.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `70e9eac16e66343e40cca5b150e383668a9851fc20b54052e6bd9fa1be7b0dd2`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2010-12-20 | 2010-12-20 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=1&tab=history) | `2b41403d6278e5a010b9a5b59b24b3e3b349fc37d31e10ea6380e011f6be074a` |
| 2 | 2011-04-15 | 2011-04-15 | RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=2&tab=history) | `a61a8728ceb4711d5a6f22b583b513fd4fa3a9003b0e79e0f7cad661f8e0aa43` |
| 3 | 2011-10-05 | 2011-10-05 | RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=3&tab=history) | `12a4e4e036ace843520fe47cb7113476a4e9d7adf693ffdaa3b3340e1e3b55d9` |
| 4 | 2012-04-18 | 2012-04-18 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=4&tab=history) | `51580889575ff5893c6148419ce53dfa9338a929ce5048d5dc6521dd1190329a` |
| 5 | 2012-11-09 | 2012-11-09 | RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=5&tab=history) | `ef382093d098153dbee9344f8e49a4ec4b7db1501b66e2e82c8726d949336b75` |
| 6 | 2013-03-12 | 2013-03-12 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=6&tab=history) | `c6cb29561e47d1351e8be4a4a5e6ce7c2384fe71dd4dad5fc4ffbe9dae5f197e` |
| 7 | 2013-08-27 | 2013-08-27 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=7&tab=history) | `68f1fc3349bffb82fd0ad5d8031e4cb855283aa3b2f5bf6ff8e4072b25b14bbd` |
| 8 | 2014-05-02 | 2014-05-02 | COMPLETED | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=8&tab=history) | `68474d0ae059831658885b85e1daf3be404ed7991e247cdc2d65c2ba6cd0e639` |
| 9 | 2014-10-10 | 2014-10-10 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Contacts/Locations, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, References, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=9&tab=history) | `91dda507d28b15877972684ae00a251797e09cd2bb8d0447661d69f592c3c7de` |
| 10 | 2017-09-28 | 2017-09-28 | COMPLETED | INTERVENTIONAL | Limitations and Caveats, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT01263717?a=10&tab=history) | `81f11902464f8176f00608d889b2378edbf3d351cc875f02532fea2df69c9e6e` |